Edwards tweaks 2025 outlook amid strong Q2 heart therapy performance [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT) business segments. The California-based company now expects an adjusted profit near the upper end of its previously forecast range of $2.40 to $2.50 per share for 2025, corresponding to profits between $5.9bn and $6.1bn for the year. Shares in Edwards were up by more than 5% in pre-trading on 25 July following the result's announcement on 24 July. Edwards financials revealed total sales of $1.53bn in Q2 2025, marking an 11.9% rise on Q2 2024 sales of $1.39bn. Edwards TAVR segment grew to $1.1bn in Q2 2025, an 8.9% increase on Q2 2024. The company said the increase was chiefly driven by the continued adoption of its SAPIEN technology, with clinical conversations around its EARLY TAVR trial (NCT03042104) data bringing a renewed focus to streamlining the management of patients with severe aortic stenosis (AS). The trial results demonstrated that early intervention for severe AS before sympto
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook [Yahoo! Finance]Yahoo! Finance
- Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors' Thesis? [Yahoo! Finance]Yahoo! Finance
- What Analysts Think Is Changing In The Boston Scientific Growth Story [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX): Assessing Valuation After a Strong Multi-Year Run and Recent Pullback [Yahoo! Finance]Yahoo! Finance
- Boston Scientific: Gangbusters Growth, And A Valuation To Match [Seeking Alpha]Seeking Alpha
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/8/25 - Form 3
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- BSX's page on the SEC website